Literature DB >> 9293787

Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer.

Y Nishiyama1, Y Kawasaki, Y Yamamoto, K Fukunaga, K Satoh, H Takashima, M Ohkawa, M Tanabe.   

Abstract

UNLABELLED: We evaluated the usefulness of 99mTc-MIBI scintigraphy in primary lung cancer in comparison with 201Tl-chloride scintigraphy.
METHODS: There were 45 patients with primary lung cancer. All patients underwent dual-isotope imaging with 201Tl-chloride and 99mTc-MIBI. Regions of interest were placed over the tumors (T) and contralateral normal lung tissue (N) on one coronal view in the SPECT, and T/N ratio and retention index were calculated.
RESULTS: The positive rate was 98% in both the early and delayed images for 201Tl-chloride and 96% in the early and 89% in the delayed image for 99mTc-MIBI. Both early and delayed T/N ratios for 201Tl-chloride were higher than those for 99mTc-MIBI. There was no significant correlation between T/N ratio and histological type of tumor in both images. However, in both images, there was a tendency for the early and delayed ratios to increase as the tumor diameter became larger. The retention index of 201Tl-chloride was higher than that of 99mTc-MIBI. There were no significant differences in the retention index with respect to the histological type and tumor size.
CONCLUSION: The results of this preliminary clinical study suggest that 99mTl-MIBI can depict primary lung cancer similar to 201Tl-chloride. However, T/N ratio and retention index of 99mTc-MIBI in the tumor areas are significantly lower compared with those of 201Tl-chloride.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293787

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.

Authors:  Masaya Furuta; Miwako Nozaki; Miho Kawashima; Mamoru Iimuro; Yoshinori Kitazumi; Aya Okayama; Satoshi Natsui; Yoshio Hamashima; Koushuu Nagao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

2.  Incidental detection of hepatocellular carcinoma by SPECT myocardial perfusion imaging.

Authors:  Pradeep Bhambhvani; Eva Dubovsky; Jaekyeong Heo; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

3.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

Authors:  Jean-Luc Moretti; Nathalie Hauet; Meltem Caglar; Olivier Rebillard; Zeynep Burak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

4.  Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.

Authors:  M Piga; G P Farina; G L Loi; A Serra; M A Calia; L Lai; G Zucca; S Mariotti
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

5.  Lung 99mTc-MIBI scintigraphy: impact on diagnosis of solitary pulmonary nodule.

Authors:  Katarina Nikoletic; Silvija Lucic; Andrea Peter; Violeta Kolarov; Radmila Zeravica; Dolores Srbovan
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

6.  The significance of incidental noncardiac findings in Tc-99m sestamibi myocardial perfusion imaging: illustrated by a case.

Authors:  S N Chatziioannou; C Alfaro-Franco; W H Moore; L Alanis-Williams; R D Dhekne; P V Ford
Journal:  Tex Heart Inst J       Date:  1999

7.  Monitoring of biological responses of tumor cells after irradiation with 99mTc-MIBI--an in vitro study.

Authors:  J Xia; H Wu; M Zhao; Z Xianyu
Journal:  J Tongji Med Univ       Date:  2001

8.  HIV-associated lymphocytic interstitial pneumonitis causes diffuse sestamibi lung uptake in myocardial perfusion imaging.

Authors:  Ramesh Gadiraju; Srinivas Bommireddipalli; Rajani Rangray; E Gordon DePuey
Journal:  Radiol Case Rep       Date:  2015-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.